allantoin has been researched along with Multiple Sclerosis in 3 studies
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yeo, T | 1 |
| Bayuangga, H | 1 |
| Augusto-Oliveira, M | 1 |
| Sealey, M | 1 |
| Claridge, TDW | 1 |
| Tanner, R | 1 |
| Leppert, D | 1 |
| Palace, J | 1 |
| Kuhle, J | 1 |
| Probert, F | 1 |
| Anthony, DC | 1 |
| Becker, BF | 2 |
| Kastenbauer, S | 2 |
| Ködel, U | 1 |
| Kiesl, D | 1 |
| Pfister, HW | 1 |
| Kieseier, BC | 1 |
3 other studies available for allantoin and Multiple Sclerosis
| Article | Year |
|---|---|
Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model.
Topics: Allantoin; Animals; Biomarkers; Cytidine; Disease Models, Animal; Glucose; Glutamine; Humans; Interm | 2022 |
Urate oxidation in CSF and blood of patients with inflammatory disorders of the nervous system.
Topics: Allantoin; Blood-Brain Barrier; Brain; Central Nervous System Diseases; Guillain-Barre Syndrome; Hum | 2004 |
No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis.
Topics: Adult; Allantoin; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Oxidative Stress; Uric Acid | 2005 |